MyMD Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Major Suppliers

Major Suppliers	12 Months Ended
Dec. 31, 2015
Major Suppliers [Abstract]
Major Suppliers	Note 19 - Major Suppliers For the year ended December 31, 2015, three suppliers accounted for more than 10% of the Companys purchases. These suppliers accounted for 41% of the Companys total purchases. As of December 31, 2015, the amount due to these suppliers was $16,317. This makes the Company vulnerable to a near-term severe impact should the relationships be terminated. For the year ended December 31, 2014, one supplier accounted for more than 10% of the Companys purchases. This supplier accounted for 17% of the Companys total purchases. As of December 31, 2014, the amount due to the supplier was $11,880. This makes the Company vulnerable to a near-term severe impact should the relationships be terminated.

Major Suppliers

12 Months Ended

Dec. 31, 2015

Major Suppliers [Abstract]

Major Suppliers

Note 19 - Major Suppliers

For the year ended December 31, 2015, three suppliers accounted for more than 10% of the Companys purchases. These suppliers accounted for 41% of the Companys total purchases. As of December 31, 2015, the amount due to these suppliers was $16,317. This makes the Company vulnerable to a near-term severe impact should the relationships be terminated.

For the year ended December 31, 2014, one supplier accounted for more than 10% of the Companys purchases. This supplier accounted for 17% of the Companys total purchases. As of December 31, 2014, the amount due to the supplier was $11,880. This makes the Company vulnerable to a near-term severe impact should the relationships be terminated.